COMMUNIQUÉS West-GlobeNewswire

Skyline Medical Reports 2017 Third Quarter Financial Results

14/11/2017 - 23:30

MINNEAPOLIS, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ: SKLN ) (“Skyline” or the “Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, [...]

MEDITE Cancer Diagnostics Reports 2017 Third Quarter Financial Results

14/11/2017 - 23:25

ORLANDO, Fla., Nov. 14, 2017 (GLOBE NEWSWIRE) -- MEDITE Cancer Diagnostics, Inc. (OTCQB:MDIT) (the “Company”), specializing in the development, manufacturing and marketing of molecular biomarkers and premium medical [...]

Sienna Senior Living Inc. Reports 2017 Third Quarter Financial Results

14/11/2017 - 22:54

MARKHAM, Ontario, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA ) today announced its financial results for the three and nine months ended September 30, 2017. The [...]

Tivity Health Comments on North Tide Capital’s Plan for Divestiture of Tivity Stock

14/11/2017 - 22:50

North Tide Intends to Sell Remaining Holdings in Tivity Health via a 10b5-1 Trading Plan as Part of Wind Down of its Funds Conan Laughlin to Continue to Serve on Tivity Health Board of Directors FRANKLIN, Tenn., Nov. 14 [...]

Precision Optics Corporation, Inc. Announces Operating Results for the First Quarter of Fiscal Year 2018 Ended September 30, 2017

14/11/2017 - 22:30

GARDNER, Mass., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB:PEYE) (the “Company”) today announced operating results on an unaudited basis for its first quarter ended September 30, 2017. [...]

Profound Medical Corp. to Present at the 29th Annual Piper Jaffray Healthcare Conference

14/11/2017 - 22:30

TORONTO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]

Real World Data Analysis Shows That Persistent Hypertriglyceridemia Despite Statin Therapy is Associated With Cardiovascular Risk

14/11/2017 - 22:30

BEDMINSTER, N.J. and DUBLIN, Ireland, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]

Veritas Pharma Initiates Cancer Research with Dr. Dmitri Petchkovski

14/11/2017 - 22:15

VANCOUVER, British Columbia, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT); (OTC:VRTHF); and (Frankfurt: 2VP ), (“Veritas” or the “Company”) announces that it has initiated a cancer research project to [...]

The Cooper Companies to Present at BMO Healthcare Conference

14/11/2017 - 22:15

PLEASANTON, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) will present at the BMO Prescriptions for Success Healthcare Conference in New York, NY, on December 14, 2017. Daniel G. [...]

Molecular Templates Strengthens Management Team with Appointment of Adam Cutler as Chief Financial Officer

14/11/2017 - 22:15

Company Also Added Key Members to the Senior Management Team Barbara Ruskin J.D. Ph.D. Appointed SVP, General Counsel and Chief Patent Officer Nenad Sarapa M.D. M.S. Appointed SVP of Clinical Development Conrad Jordaan [...]

Precipio Appoints Samuel D. Riccitelli as Chairman of the Board of Directors and Elects David Cohen as Director

14/11/2017 - 22:15

NEW HAVEN, Conn., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO ), today announced that on November 8, 2017, Precipio’s Board of Directors (the “Board”) appointed Samuel D. Riccitelli as Chairman, [...]

Asterias Biotherapeutics Reports Third Quarter Financial Results and Recent Developments

14/11/2017 - 22:10

- Continues to execute on key clinical programs and streamline cost structure - - Conference call and webcast today, November 14, at 4:30 p.m. ET - FREMONT, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Asterias [...]

HealthEquity Sets Date to Announce Third Quarter Results

14/11/2017 - 22:05

DRAPER, Utah, Nov. 14, 2017 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY ) (“HealthEquity” or the “Company”), the largest HSA non-bank custodian, today announced that it plans to release its third quarter of [...]

aTyr Pharma Announces Third Quarter 2017 Operating Results and Provides Corporate Update

14/11/2017 - 22:05

- Initiation of Phase 1 clinical trial of iMod.Fc on-track for this quarter - - Selection of antibody for ORCA program on-track for this quarter - SAN DIEGO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: [...]

Evoke Pharma Reports Third Quarter 2017 Results and Highlights

14/11/2017 - 22:05

Announced positive topline results from comparative exposure pharmacokinetic (PK) trial for Gimoti™ 505(b)(2) New Drug Application (NDA) submission on track for Q1 2018 filing Partnered with the Patheon division of [...]

Entellus Medical to Participate in Upcoming Investor Conferences

14/11/2017 - 22:05

PLYMOUTH, Minn., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ: ENTL ), a medical technology company focused on delivering minimally invasive ENT procedures, today announced the Company plans to [...]

Fluidigm to Participate in the 29th Annual Piper Jaffray Healthcare Conference

14/11/2017 - 22:05

SOUTH SAN FRANCISCO, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced that Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer, will participate in [...]

Cesca Therapeutics Announces Financial Results for the Three Months Ended September 30, 2017 and Provides Corporate Update

14/11/2017 - 22:05

RANCHO CORDOVA, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL ), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced [...]

Achillion Announces Proposed Secondary Offering of Common Stock

14/11/2017 - 22:03

NEW HAVEN, Conn., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (“Achillion”) (NASDAQ: ACHN ) today announced that Johnson & Johnson Innovation-JJDC, Inc. (“JJDC”), an existing stockholder of [...]